Funding Human Clinical Trials
It is an established fact that a disproportionately large number of promising cancer therapies hit a financial roadblock before they are are able to begin human trials or during early phases of those trials. CanceRx recognizes that by removing this financial roadblock it could open the lanes for a greater number of potential cures. Therefore CanceRx concentrates on providing funding opportunities for these trials.
Deploys a new application of a well-established finance mechanism to fund human-phase clinical cancer research.
Accelerates the delivery of targeted, more effective personalized cancer treatments for patients.
Structures a diversified portfolio of highly selective promising clinical phase cancer therapeutics.
Leverages high-impact charitable giving with the utilization of long-term bond financing to match the speed of science.